FDA Inspection 1245257 — Mares-Elaine Strempler, M.D., Ph.D.
The FDA completed an inspection of Mares-Elaine Strempler, M.D., Ph.D. on Jul 5, 2024 in Berlin. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 5, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Berlin (Germany)
Additional Details
Clinical BA/BE